Literature DB >> 22191582

Long-term follow-up of febrile infection-related epilepsy syndrome.

Katherine B Howell1, Kamornwan Katanyuwong, Mark T Mackay, Catherine A Bailey, Ingrid E Scheffer, Jeremy L Freeman, Samuel F Berkovic, A Simon Harvey.   

Abstract

PURPOSE: Febrile infection-related epilepsy syndrome (FIRES) is an increasingly recognized epileptic syndrome that presents with multifocal refractory status epilepticus in previously normal children and evolves into a chronic, refractory, focal epilepsy with associated cognitive and behavioral difficulties. Herein we describe the features of the chronic epilepsy and critically review evidence for the etiology of this syndrome.
METHODS: Seven patients with FIRES were studied. The duration of follow-up in six survivors was 5-17 years. Clinical, electroencephalography (EEG), neuroimaging, and other investigative findings during the acute and chronic phases were reviewed. KEY
FINDINGS: These previously normal children presented with a febrile illness and status epilepticus that was refractory to antiepileptic medications in all children, to immunotherapies (including immunoglobulin, corticosteroids, plasma exchange, and rituximab) in four, and to acute vagus nerve stimulation in one. Markers of cerebral inflammation were few and response to antiepileptic and immunomodulatory therapies was poor. Evolution to chronic epilepsy occurred without a silent period. Seizure characteristics in the chronic phase were strikingly stereotyped and similar to the acute phase, with head and eye version, unilateral facial jerking, asymmetric tonic posturing, and unilateral limb jerking in all patients. Electrographic ictal onset was lateralized in all recorded seizures, unilateral in one patient, and independent bilateral in three. Seizures were refractory to multiple antiepileptic medications in all patients and partly responsive to chronic vagus nerve stimulation in two patients. Moderate to severe intellectual impairment was noted in four patients, and borderline intellectual abilities were noted in two. Magnetic resonance imaging (MRI) in the chronic phase was normal in three patients and showed mild diffuse cortical atrophy and/or mild hippocampal atrophy or sclerosis in three. SIGNIFICANCE: The similar perirolandic and perisylvian features of acute and chronic seizures, the lack of a silent period, the absence of evidence of cerebral inflammation, and the poor response to immunotherapies suggest FIRES is best conceptualized as a chronic epilepsy with explosive onset, not a remote-symptomatic epilepsy with an acute inflammatory antecedent. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22191582     DOI: 10.1111/j.1528-1167.2011.03350.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  10 in total

1.  NORSE Versus FIRES: What's in a Name?

Authors:  Katherine Nickels
Journal:  Epilepsy Curr       Date:  2018 Sep-Oct       Impact factor: 7.500

Review 2.  Generation of Febrile Seizures and Subsequent Epileptogenesis.

Authors:  Bo Feng; Zhong Chen
Journal:  Neurosci Bull       Date:  2016-08-25       Impact factor: 5.203

Review 3.  Treatment of epileptic encephalopathies.

Authors:  Amy McTague; J Helen Cross
Journal:  CNS Drugs       Date:  2013-03       Impact factor: 5.749

4.  Hippocampal Changes in Febrile Infection-Related Epilepsy Syndrome (FIRES).

Authors:  Amit Agarwal; Shyamsunder Sabat; Krishnamurthy Thamburaj; Sangam Kanekar
Journal:  Pol J Radiol       Date:  2015-08-17

5.  Use of Magnesium Sulfate Infusion for the Management of Febrile Illness-Related Epilepsy Syndrome: A Case Series.

Authors:  Wei Wei Tan; Derrick W S Chan; Jan Hau Lee; Terrence Thomas; Anuradha P Menon; Yoke Hwee Chan
Journal:  Child Neurol Open       Date:  2015-03-23

Review 6.  Roseolovirus-associated encephalitis in immunocompetent and immunocompromised individuals.

Authors:  Joseph Ongrádi; Dharam V Ablashi; Tetsushi Yoshikawa; Balázs Stercz; Masao Ogata
Journal:  J Neurovirol       Date:  2016-08-18       Impact factor: 2.643

Review 7.  Therapeutic Options for Patients with Refractory Status Epilepticus in Palliative Settings or with a Limitation of Life-Sustaining Therapies: A Systematic Review.

Authors:  Laurent M Willems; Sebastian Bauer; Kolja Jahnke; Martin Voss; Felix Rosenow; Adam Strzelczyk
Journal:  CNS Drugs       Date:  2020-08       Impact factor: 5.749

8.  Long-term outcomes of status epilepticus: A critical assessment.

Authors:  Claudine Sculier; Marina Gaínza-Lein; Iván Sánchez Fernández; Tobias Loddenkemper
Journal:  Epilepsia       Date:  2018-08-26       Impact factor: 5.864

Review 9.  Neurocritical care and target immunotherapy for febrile infection-related epilepsy syndrome.

Authors:  Hiroshi Sakuma; Asako Horino; Ichiro Kuki
Journal:  Biomed J       Date:  2020-04-21       Impact factor: 4.910

10.  Proposal to optimize evaluation and treatment of Febrile infection-related epilepsy syndrome (FIRES): A Report from FIRES workshop.

Authors:  Sookyong Koh; Elaine Wirrell; Annamaria Vezzani; Rima Nabbout; Eyal Muscal; Marios Kaliakatsos; Ronny Wickström; James J Riviello; Andreas Brunklaus; Eric Payne; Antonio Valentin; Elizabeth Wells; Jessica L Carpenter; Kihyeong Lee; Yi-Chen Lai; Krista Eschbach; Craig A Press; Mark Gorman; Coral M Stredny; William Roche; Tara Mangum
Journal:  Epilepsia Open       Date:  2021-01-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.